Emerging therapeutic opportunities for skeletal restoration.

Current drugs for osteoporosis primarily prevent bone loss, and there is a substantial need for treatments that could reduce fracture risk further. Rosen and colleagues describe recent insights into skeletal physiology that are providing the basis for novel therapeutics to promote bone formation, and discuss the regulatory and commercial challenges for these agents.